Core Laboratories' CEO Discusses Q1 2012 Results - Earnings Call Transcript

Core Laboratories NV (CLB)

Q1 2012 Results Earnings Call

April 19, 2012 8:30 AM ET

Executives

David Demshur – Chairman, President and CEO

Richard Bergmark – Executive Vice President and CFO

Monty Davis – Chief Operating Officer

Analysts

Rob MacKenzie – FBR Capital Markets

James West – Barclays Capital

Veny Aleksandrov – Pritchard Capital Partners

Blake Hutchinson – Howard Weil, Inc.

John Daniels – Simmons & Company

Presentation

Operator

Good morning. My name is Erika and I'll be your conference operator today. At this time, I would like to welcome everyone to the Core Lab Q1 2012 Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks there will be a question and answer session. (Operator Instructions)

Thank you, I would now like to turn the call over to Mr. David Demshur. Mr. Demshur, you may begin your conference.

David Demshur

Thank you, Erika. I'd like to say good morning in North America, good afternoon in Europe and good evening in Asia Pacific. We'd like to welcome all of our shareholders, analysts, and most importantly, our employees to Core Laboratories first quarter 2012 earnings conference call. This morning I am joined by Dick Bergmark, Core's Executive Vice President and CFO. Also this morning we are again joined by Core's COO Monty Davis who'll present the detailed operational review.

The call will be divided into five segments. Dick will start by making remarks regarding forward-looking statements, then we'll come back and give a brief investor update and highlight the three financial tenets by which Core's executive management executes the company's growth strategies.

If you liked this article you might like

Autodesk, Burlington Stores, Alibaba: 'Mad Money' Lightning Round

Stocks Eclipsed by Nothing: Cramer's 'Mad Money' Recap (Monday 8/21/17)

Greenlight Capital Quadrupled General Motors Stake in Activist Push

Analysts Actions -- Costco, McDonald's, GW Pharma, Kinder Morgan and More

Market Recon: The Banks Trade Will Become a Yield Curve Watch